WHO Europe's 53 member states adopt first regional roadmap for AI in health to 2033
The plan sets four priority areas, aligns with the EU AI Act and European Health Data Space, and backs a new WHO office on AI.
By World Health AI Editorial
All 53 member states of the WHO European Region have unanimously adopted the region's first "Roadmap for action on artificial intelligence in health", WHO/Europe announced on 29 October 20261. Ministers and delegates approved it at the 76th session of the WHO Regional Committee for Europe1.
What the roadmap sets out
The roadmap runs from 2026 to 2033 and groups its work into four linked priority areas1:
- governance and leadership;
- ethical, regulatory and legal frameworks;
- data and digital infrastructure;
- capacity-building, implementation support and learning.
In practice, WHO/Europe says countries should build AI into national health priorities through dedicated or adapted strategies, with clear institutional responsibilities and sustained investment1. It asks for safeguards and governance across the life cycle of an AI tool, and puts weight on data quality, interoperability, secure access and cybersecurity1. The final strand concerns turning AI into value for health systems through workforce skills, real-world implementation and evaluation1.
WHO/Europe based the roadmap on its first region-wide assessment of AI readiness for health, published in 2025, which drew responses from 50 of the 53 member states1. An implementation guide accompanies it, designed for countries at different levels of digital and AI maturity1. Member states also supported setting up a new WHO office on AI to provide evidence, technical assistance and knowledge exchange1.
Dr Corinne Capuano, Officer-in-Charge for WHO/Europe, said: "These are challenges no country can solve alone"1.
What it means for the market
For suppliers selling AI into European health systems, the most useful detail is alignment. WHO/Europe says the roadmap is built to avoid fragmentation by fitting with the EU Artificial Intelligence Act, the AI Continent Action Plan, the Apply AI Strategy, the European Health Data Space, the Medical Device Regulation and the GDPR, as well as the OECD policy checklist on scaling AI in health1. That points to a common reference for health ministries outside the EU as well as inside it, since the region spans Europe and Central Asia1.
For health system buyers, the emphasis on life-cycle governance and real-world evaluation suggests that ministries following the roadmap will look for evidence after deployment, not only at the point of purchase1. The weight given to interoperability and secure data access matches the direction already set by the European Health Data Space1.
The source does not give any budget for the roadmap or the new office, a timetable for national strategies, or a mechanism for tracking whether countries follow it1. How far it changes procurement or regulation will depend on what individual member states adopt.
Caveats
The roadmap is a shared regional vision approved by health ministers, and WHO/Europe describes it in terms of priorities and a framework rather than binding rules1. The readiness assessment behind it covered 50 of the 53 member states1. WHO/Europe has said the roadmap sits alongside its European Programme of Work for 2026 to 2030 and its regional digital health action plan, which runs to 20301.
Sources
- 1Governments across Europe and Central Asia unanimously adopt new vision for AI in health care · WHO Regional Office for Europe
This briefing summarises publicly available research and reporting for information only. It is not medical, investment or legal advice. Follow the sources listed for the primary research and reporting.